The stimulation of neoangiogenesis in the ischemic human heart by the growth factor FGF: first clinical results.

Abstract

It is therefore our opinion that employment of the human growth factor FGF represents a useful extension to bypass surgery, particularly for patients with an additional peripheral stenosis that cannot be operatively revascularized.